The company that makes EpiPens certainly deserves public scorn for its avaricious price hike, but the blame isn’t Mylan’s alone. The same Congress that professes to abhor this exploitative greed shares the blame, too. This is, after all, a Congress that refuses to allow the federal government to use its buying power to rein in
↧